STOCK TITAN

Hayfin group sells millions of HTFL shares (HTFL) — filings show dispositions

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Hayfin-related entities reported changes in beneficial ownership of Heartflow, Inc. (Class A common stock). Several Hayfin reporting persons disclosed dispositions during the three months ended March 31, 2026, including the disposition of 4,648,410, 3,104,987 and 1,543,422 shares by related entities. The filing uses an 85,757,754 share base for Class A common stock outstanding as of February 28, 2026 to calculate percentages. Individual cover-page lines show remaining shared voting/dispositive holdings of 633,505, 530,610 and 102,895 shares for specific Hayfin entities, reported as approximately 0.7%, 0.6% and 0.1% of the class, respectively.

Positive

  • None.

Negative

  • None.

Insights

Hayfin entities report multi-entity dispositions reducing indirect holdings.

Cover-page entries and comments state specific share dispositions during the three months ended March 31, 2026, with the filing using 85,757,754 shares outstanding as of February 28, 2026 for percent calculations. Reported remaining shared dispositive/voting positions include 633,505, 530,610 and 102,895 shares.

Future investor impact depends on additional sales or transfers by these holders; the filing records prior disposals but does not state trading method or proceeds. Subsequent filings or trading disclosures would clarify any continuing overhang or further reductions.

Group-level disclosures show indirect ownership and customary disclaimers about beneficial ownership.

The schedule explains inter-entity relationships (e.g., Hayfin Management Holdings Limited may be deemed to beneficially own shares held by affiliated vehicles) and includes standard disclaimers that reporting persons disclaim beneficial ownership except to the extent of pecuniary interest. Specific cover-page rows tie voting and dispositive power to each named entity.

These attribution notes matter for governance: they identify which Hayfin entities retain shared voting/dispositive power and quantify those holdings as of the disclosed dates for shareholder records and any regulatory thresholds.

Shares outstanding 85,757,754 shares Class A common stock outstanding as of <date>February 28, 2026</date>
Disposition — Hayfin Management (indirect) 4,648,410 shares Disposed during three months ended <date>March 31, 2026</date>
Disposition — Hayfin Heartflow UK 3,104,987 shares Disposed during three months ended <date>March 31, 2026</date>
Disposition — Hayfin Tourmaline LuxCo 1,543,422 shares Disposed during three months ended <date>March 31, 2026</date>
Remaining shared holding — entity A 633,505 shares Shared voting/dispositive power reported on cover page
Remaining shared holding — entity B 530,610 shares Shared voting/dispositive power reported on cover page
Remaining shared holding — entity C 102,895 shares Shared voting/dispositive power reported on cover page
disposition regulatory
"Comment for Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026"
beneficially owned regulatory
"Amount beneficially owned: (a) The information required by Item 4(a) is set forth in Row 9"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive power regulatory
"Shared Dispositive Power 633,505.00"
pecuniary interest financial
"each disclaim beneficial ownership of such securities except to the extent of their pecuniary interests therein"





42238D107

(CUSIP Number)
02/06/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 4,648,410 shares of Class A Common Stock indirectly held on behalf of the Reporting Person. The percentage ownership reported in Row 11 was calculated based upon an aggregate of 85,757,754 shares of Class A Common Stock outstanding as of February 28, 2026 as reported in Heartflow, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission on March 18, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Rows 6, 8 and 9 reflect the disposition, during the three months ended March 31, 2026, of 3,104,987 shares of Class A Common Stock held by the Reporting Person. The percentage ownership reported in Row 11 was calculated based upon an aggregate of 85,757,754 shares of Class A Common Stock outstanding as of February 28, 2026 as reported in Heartflow, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission on March 18, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 1,543,422 shares of Class A Common Stock held by the Reporting Person. The percentage ownership reported in Row 11 was calculated based upon an aggregate of 85,757,754 shares of Class A Common Stock outstanding as of February 28, 2026 as reported in Heartflow, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission on March 18, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 633,508 shares of Class A Common Stock indirectly held on behalf of the Reporting Person. The percentage ownership reported in Row 11 was calculated based upon an aggregate of 85,757,754 shares of Class A Common Stock outstanding as of February 28, 2026 as reported in Heartflow, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission on March 18, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 633,508 shares of Class A Common Stock indirectly held on behalf of the Reporting Person. The percentage ownership reported in Row 11 was calculated based upon an aggregate of 85,757,754 shares of Class A Common Stock outstanding as of February 28, 2026 as reported in Heartflow, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission on March 18, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G




Comment for Type of Reporting Person: Row 6, Row 8 and Row 9 reflect the disposition, during the three months ended March 31, 2026, of 100.0% of the shares of Class A Common Stock indirectly held on behalf of the Reporting Person.


SCHEDULE 13G



Hayfin Management Holdings Limited
Signature:By: /s/ David Rushford
Name/Title:David Rushford, Authorised Signatory
Date:05/11/2026
Hayfin Heartflow UK Limited
Signature:By: /s/ Jessica Gray
Name/Title:Jessica Gray, Director
Date:05/11/2026
Hayfin Tourmaline LuxCo S.a.r.l.
Signature:By: /s/ Jean-Christophe Gladek
Name/Title:Jean-Christophe Gladek, Manager
Date:05/11/2026
Signature:By: /s/ Virginie Brousmiche
Name/Title:Virginie Brousmiche, Manager
Date:05/11/2026
Hayfin Healthcare Opportunities Fund GP S.a.r.l.
Signature:By: /s/ Jean-Christophe Gladek
Name/Title:Jean-Christophe Gladek, Manager
Date:05/11/2026
Signature:By: /s/ Virginie Brousmiche
Name/Title:Virginie Brousmiche, Manager
Date:05/11/2026
Hayfin Healthcare Opportunities Invest LP
Signature:acting by its general partner, HAYFIN HF GP LLC, acting by its sole member, Hayfin Healthcare Opportunities Fund GP S.a.r.l., By: /s/ Jean-Christophe
Name/Title:Jean-Christophe Gladek, Manager
Date:05/11/2026
Signature:By: /s/ Virginie Brousmiche
Name/Title:Virginie Brousmiche, Manager
Date:05/11/2026
Hayfin SOF III GP S.a.r.l.
Signature:By: /s/ Jean-Christophe Gladek
Name/Title:Jean-Christophe Gladek, Manager
Date:05/11/2026
Signature:By: /s/ Virginie Brousmiche
Name/Title:Virginie Brousmiche, Manager
Date:05/11/2026
Hayfin Special Opportunities Fund III SCSp
Signature:acting by its general partner, HAYFIN SOF III GP S.A.R.L., By: /s/ Jean-Christophe Gladek
Name/Title:Jean-Christophe Gladek, Manager
Date:05/11/2026
Signature:By: /s/ Virginie Brousmiche
Name/Title:Virginie Brousmiche, Manager
Date:05/11/2026
Hayfin Hostplus GP Limited
Signature:By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin Hostplus LP
Signature:acting by its general partner, HAYFIN HOSTPLUS GP LIMITED, By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin Chief GP Limited
Signature:By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin Chief LP
Signature:acting by its general partner, HAYFIN CHIEF GP LIMITED, By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
SunHay GP Limited
Signature:By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
SunHay LP
Signature:acting by its general partner, SUNHAY GP LIMITED, By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin Big Cypress GP Limited
Signature:By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin Big Cypress LP
Signature:acting by its general partner, HAYFIN BIG CYPRESS GP LIMITED, By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin Hamilton GP Limited
Signature:By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin Hamilton LP
Signature:acting by its general partner, HAYFIN HAMILTON GP LIMITED, By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin Opal 2020 GP Limited
Signature:By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin Opal 2020 (A) LP
Signature:acting by its general partner, HAYFIN OPAL 2020 GP LIMITED, By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin Opal 2020 (B) LP
Signature:acting by its general partner, HAYFIN OPAL 2020 GP LIMITED, By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin SOF II GP Limited
Signature:By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin Special Opportunities Fund II LP
Signature:acting by its general partner, HAYFIN SOF II GP LP, acting by its general partner, HAYFIN SOF II GP LIMITED, By: /s/ Anneka Bavalia
Name/Title:Anneka Bavalia, Director
Date:05/11/2026
Hayfin SOF III AIV GP S.a.r.l.
Signature:By: /s/ Tej Gujadhur
Name/Title:Tej Gujadhur, Manager
Date:05/11/2026
Signature:By: /s/ Virginie Brousmiche
Name/Title:Virginie Brousmiche, Manager
Date:05/11/2026
Hayfin AUS AIV LP - Hostplus Series
Signature:acting by its general partner, HAYFIN AUS AIV GP LLC, acting by its member, HAYFIN SOF III AIV GP S.A.R.L. -, By: /s/ Tej Gujadhur
Name/Title:Tej Gujadhur, Manager
Date:05/11/2026
Signature:By: /s/ Virginie Brousmiche
Name/Title:Virginie Brousmiche, Manager
Date:05/11/2026
Hayfin Special Opportunities Fund III AIV LP
Signature:acting by its general partner, HAYFIN SOF III AIV GP LLC, acting by its sole member, HAYFIN SOF III AIV GP S.A.R.L., By: /s/ Tej Gujadhur
Name/Title:Tej Gujadhur, Manager
Date:05/11/2026
Signature:By: /s/ Virginie Brousmiche
Name/Title:Virginie Brousmiche, Manager
Date:05/11/2026
Hayfin AUS AIV LP - AUS SOF III Series
Signature:acting by its general partner, HAYFIN AUS AIV GP LLC, acting by its member, HAYFIN SOF III AIV GP S.A.R.L., By: /s/ Tej Gujadhur
Name/Title:Tej Gujadhur, Manager
Date:05/11/2026
Signature:By: /s/ Virginie Brousmiche
Name/Title:Virginie Brousmiche, Manager
Date:05/11/2026

FAQ

What did Hayfin disclose about HTFL ownership?

Hayfin reported dispositions during the three months ended March 31, 2026, including sales of 4,648,410, 3,104,987 and 1,543,422 shares by affiliated entities, with percent calculations using 85,757,754 shares outstanding as of February 28, 2026.

How much Class A stock does Hayfin Management Holdings Limited still report?

Hayfin Management Holdings Limited shows shared voting and dispositive power over 633,505 shares, reported as approximately 0.7% of Class A common stock based on 85,757,754 shares outstanding as of February 28, 2026.

Which Hayfin entities reported zero remaining holdings for HTFL?

Several Hayfin entities (for example, Hayfin SOF III GP S., Hayfin Special Opportunities Fund III SCSp and others listed) show 0.00 shares and 0.00% ownership after dispositions during the referenced period, per the cover-page entries and comments.

On what basis were percentage ownership figures calculated?

Percentage ownership figures in Row 11 were calculated using an aggregate of 85,757,754 Class A shares outstanding as of February 28, 2026, as reported in Heartflow's Annual Report on Form 10-K for the fiscal year ended December 31, 2025.